جست‌وجوی استاد و پژوهشگر

David E. Reichmanمشاهده پروفایل

دانشیار

• Reproductive Endocrinology
• Infertility Treatment
• Fertility Preservation
• +۶ مورد دیگر

Dr. David E. Reichman is an Associate Professor of Clinical Obstetrics and Gynecology at Weill Cornell Medical College and a board-certified reproductive endocrinology and infertility specialist . He practices at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine in New York City, with a focus on reproductive endocrinology , fertility preservation , and minimally invasive surgery . Dr. Reichman graduated Cum Laude from Yale University, received his medical degree from Weill Cornell Medical College, and completed residency and fellowship at Harvard Medical School and NewYork-Presbyterian/Weill Cornell Medical Center, respectively. Double board-certified in OB/GYN and reproductive endocrinology Active member of the American Society for Reproductive Medicine Lectures nationally and internationally on reproductive health Dr. Reichman’s research spans reproductive endocrinology , embryology , and fertility preservation , with a focus on ovarian stimulation protocols , congenital uterine anomalies , and minimally invasive surgical techniques . His work includes peer-reviewed studies on antimüllerian hormone (AMH) utility , time-lapse embryo imaging , and hCG administration in IVF cycles . He has published 27 peer-reviewed articles and 9 textbook chapters. Scientific awards include the K.Y. Cha Award in Stem Cell Technology , Abby and Howard Milstein Research Award , and Cornell’s Award for Excellence in Medical Education (2018, 2023). Dr. Reichman also serves on editorial boards for Journal of Assisted Reproduction and Genetics and Fertility & Sterility .

Anna Caiمشاهده پروفایل

مدرس

• Mathematical Biology
• Biomathematics
• Mathematical Modeling
• +۳ مورد دیگر

Dr. Anna Cai is a Lecturer in the Department of Applied Mathematics within the School of Mathematics & Statistics at the University of New South Wales (UNSW), a position she has held since 2011. Prior to this, she served as a postdoctoral researcher and lecturer at the University of California, Irvine from 2007 to 2011. Her educational background: Ph.D., The University of Melbourne, 2008 B.Sc. (First Class Honours), The University of Melbourne, 2004 Dr. Cai's research centers on Mathematical Biology , with specialization in cell migration dynamics , developmental pattern formation , and robustness in biological systems . She employs multi-scale mathematical modeling and stochastic analysis to investigate phenomena ranging from wound healing to zebrafish hindbrain development. Her work bridges theoretical mathematics with experimental biology to decode fundamental mechanisms governing cellular behavior and morphogenesis. Analysis of her 11 publications (2006-2015) reveals an evolutionary trajectory from foundational work on cell migration mechanics to sophisticated studies of developmental robustness. Early research established mathematical frameworks for wound-healing assays and immune cell dynamics, while later work pioneered noise-driven pattern formation models in zebrafish. A unifying thread is her focus on how biological systems maintain precision despite environmental fluctuations. Administrative responsibilities include: Applied representative on the postgraduate review committee UNSW study abroad and exchange course authority Current teaching assignments: MATH2121: Theory and Applications of Differential Equations MATH2018: Engineering Mathematics 2D Prior courses taught: MATH3041: Mathematical Modeling for Real World Systems MATH6781: Biomathematics

Adriana B Ferreiraمشاهده پروفایل

دانشیار

• Alzheimer's Disease
• Cell Biology
• Cytoskeleton
• +۷ مورد دیگر

Adriana B Ferreira, MD, PhD is an Associate Professor in the Department of Cell and Developmental Biology at the Feinberg School of Medicine, Northwestern University. She leads the Adriana Ferreira Lab which focuses on understanding the mechanisms underlying neurite degeneration and synapse loss in neurodegenerative diseases, with particular emphasis on Alzheimer's disease. Dr. Ferreira is also affiliated with the Mesulam Center for Cognitive Neurology and Alzheimer's Disease and the Northwestern University Institute of Neuroscience (NUIN). Dr. Ferreira received her medical degree (MD) from the National University of Cordoba, Argentina in 1981, followed by a PhD in Neuroscience from the same institution in 1985. Her extensive postdoctoral training includes: Neuroscience at the School of Medicine, National University of Cordoba (1985) Neuroscience at the Insitituo de Investigacion Medica (1988) Biology at the University of Virginia (1991) Cell Biology at the Marine Biological Laboratory (1992) Neuroscience at Brigham and Women's Hospital Harvard Medical School (1993) Dr. Ferreira's research primarily investigates the relationship between beta-amyloid deposition and the progressive formation of dystrophic neurites and cell death in hippocampal neurons. Her current work assesses the role of tau in neuronal degeneration mechanisms, using culture and animal models of Alzheimer's disease along with various cell and molecular biology techniques. Her work has significant implications for understanding and potentially treating neurodegenerative disorders characterized by neurite degeneration and synapse loss. Analysis of Dr. Ferreira's recent publications reveals a consistent focus on tau protein fragmentation and its role in neurodegeneration. Her research has evolved from studying basic mechanisms of neurite outgrowth and cytoskeletal organization to investigating specific tau fragments (particularly tau45-230) and their contribution to Alzheimer's disease pathology. More recently, her work has expanded to examine RNA-mediated mechanisms of neurotoxicity, including Death Induced by Survival gene Elimination (DISE) pathways in Alzheimer's disease and aging. Dr. Ferreira has received numerous awards and honors throughout her career: Young Investigator Award, National Alliance for Research in Schizophrenia and Depression (2001) Young Investigator Award, National Alliance for Research in Schizophrenia and Depression (1999) Young Women Investigator, Signa Kappa Foundation (1998) International Fellowship, CONICET (1988) National Fellowship, CONICET (1983) Special Mention (Top of the Class), National University of Cordoba. School of Medicine (1982) Dr. Ferreira serves as a Review Editor for Frontiers in Neuroscience and has been an active member of the Argentinian Research Council (Biology and Medicine Areas) since 1996. She has also contributed to scientific review processes as a reviewer for the Ministry of Health and Consumer's Affairs in Spain (2006-2007). Her long-standing membership in professional societies, including the Society for Neuroscience since 1989, demonstrates her commitment to advancing the field. The Ferreira Lab operates within the Department of Cell and Developmental Biology at Northwestern's Feinberg School of Medicine, with strong connections to the Mesulam Center for Cognitive Neurology and Alzheimer's Disease. The lab employs a range of cellular and molecular approaches to investigate neurodegenerative mechanisms, with particular expertise in neuronal cell culture models and analysis of cytoskeletal changes in neurodegeneration.

Philip Romeroمشاهده پروفایل

دانشیار

• Protein Engineering
• Computational Biology
• Machine Learning
• +۳ مورد دیگر

Philip Romero, Ph.D., is an Associate Professor in the Department of Biomedical Engineering at Duke University. He earned his doctorate from the California Institute of Technology in 2012 and leads the Romero Lab, which relocated to Duke in 2023. His research focuses on developing computational and experimental methods for protein engineering, with applications spanning therapeutics, biocatalysis, and synthetic biology. Research Interests: Romero's work integrates machine learning, microfluidics, and high-throughput experimentation to study protein fitness landscapes. Key areas include: Self-driving laboratories for autonomous protein optimization Neural network models for predicting protein functions Therapeutic enzyme engineering (ACE2, caspases, lysins) Microfluidic platforms for deep mutational scanning His recent publications demonstrate a strong emphasis on machine learning-guided protein design, with 80% of post-2022 publications involving AI/ML methods. Therapeutic applications against infectious diseases (particularly SARS-CoV-2) and microbiome engineering represent emerging directions. Lab & Advising: The Romero Lab develops novel technologies for protein engineering, including custom gene library assembly platforms and droplet microfluidics systems. Romero mentors graduate students (e.g., Nishit, who recently defended a thesis on transcription factor engineering) and has collaborated with researchers across computational biology, metabolic engineering, and virology.

Angela Depaceمشاهده پروفایل

استادیار

• Gene Regulation
• Cis-Regulatory Elements
• Transcriptional Networks
• +۵ مورد دیگر

Angela Depace is an Assistant Professor at Harvard Medical School, specializing in Gene Regulation , Cis-Regulatory Elements , and Quantitative Developmental Biology . Her research integrates experimental and computational approaches to study how transcription factors and enhancer sequences control gene expression in Drosophila embryos, with implications for evolutionary biology and synthetic biology . B.S., Molecular Biophysics and Biochemistry, Yale University Ph.D., Biochemistry, University of California, San Francisco (advisor: Jonathan Weissman) Postdoctoral Research, University of California, Berkeley (advisor: Michael Eisen) Her work focuses on unraveling the kinetic roles of transcriptional activators , the evolution of regulatory sequences , and the computational modeling of gene networks . Recent publications explore mechanistic principles of enhancer function , transcriptional synergy , and developmental precision . Scientific contributions include the NSF CAREER Award and co-authoring Visual Strategies: A Practical Guide to Graphics for Scientists and Engineers . Her lab emphasizes collaborative research , mentoring , and innovative teaching in systems biology graduate courses.

Nidhi Bansalمشاهده پروفایل

استاد

• Alternative Dairy Processing
• Non-Bovine Milk Systems
• Milk Protein Structure and Functionality
• +۴ مورد دیگر

Professor Nidhi Bansal is a leading expert in dairy and food bioprocessing at the University of Queensland (UQ) , serving as the Director of Teaching & Learning in the School of Agriculture and Food Sciences. With over 150 publications and an h-index of 38 (Google Scholar), her work bridges agricultural sciences , food chemistry , and clinical nutrition . PhD in Dairy Chemistry (University College Cork, 2007) B.Tech in Dairy Technology (SMC College of Dairy Science, 2003) Research Focus: • Non-Thermal Processing: Leading UQ's 'non-thermal processing research program' since 2011, developing pulsed electric field (PEF) and high-pressure processing (HPP) to preserve milk biomolecules while ensuring microbial safety. • Non-Bovine Milk Systems: Pioneering research on camel milk and human milk , exploring their composition, enzymology, and bioactive properties. • Milk Protein Structure: Investigating protein interactions, denaturation, and functional properties like foaming, gelling, and emulsification. Recent Article Trends highlight contributions to Precision Fermentation , Milk Foam Science , and Camel Milk Applications . Her work has been cited in 103 countries across 25 disciplines, including Medicine and Chemical Engineering . Scientific Leadership: Program Lead for the $165M Food and Beverage Accelerator (FaBA) Trailblazer Grant CI on grants exceeding $183M from NHMRC, ARC, and industry partners Director of UQ’s Education and Training Program in the Strategic University Reform Fund ($6.9M) Mentoring Excellence: Supervised 27 HDR students (12 as principal advisor) and >60 coursework students. Authored multiple Food Chemistry and Journal of Dairy Science publications with significant impact on infant nutrition and food safety .

• Neurodegenerative Diseases
• Parkinson's Disease
• Dementia with Lewy Bodies
• +۳ مورد دیگر

Dr. Daniel Erskine is a researcher affiliated with Newcastle University , focusing on neurodegenerative diseases and mitochondrial dysfunction. His work spans Parkinson's disease, dementia with Lewy bodies, and rare monogenic disorders, with a particular emphasis on alpha-synuclein pathology. Publications since 2015 address Lewy body formation, mitochondrial quality control, and neuroinflammatory mechanisms. Collaborates with professors in neurology and mitochondrial medicine, contributing to both clinical and experimental studies. Recent work explores genomic DNA damage, autophagy-NAD axis targeting, and cerebellar degeneration in mitochondrial diseases. Develops diagnostic tools like alpha-synuclein seed amplification assays and investigates neurochemical changes in disease states.

Brian D. Atheyمشاهده پروفایل

استاد

• Bioinformatics
• Pharmacogenomics
• Machine Learning
• +۸ مورد دیگر

Brian D. Athey is a Professor of Computational Medicine and Bioinformatics and Psychiatry at the University of Michigan Medical School. He serves as Michael Savageau Collegiate Professor & Chair of his department, leading interdisciplinary research in pharmacogenomics, epigenomics, and machine learning applications. His work bridges biomedical informatics with clinical insights in mental health, neurology, and drug response mechanisms. Ph.D. , Biophysics, University of Michigan (1990) B.S. , University of Michigan-Dearborn (1982) Dr. Athey’s research focuses on the pharmacoepigenome, high-throughput 4D imaging, and AI-driven pharmacogenomic pipelines. His lab develops tools for patient-specific drug response prediction, chromatin structure analysis, and next-generation sequencing assays. Collaborations span institutions like Assurex Health, tranSMART Foundation, and Johns Hopkins Medical School. His publications highlight innovations in pharmacogenomics, including AI integration for variant identification, 4D nucleome modeling, and adverse event ontologies. Recent projects address bipolar disorder treatment personalization, hypertension management, and generative AI workflows to enhance academic productivity. Scientific Awards : NIH Postdoctoral Fellowship 1990-1991 NIH Postdoctoral Fellowship 1991-1993 Advisees & Collaborations : His lab mentors PhD and Masters students in bioinformatics and biostatistics, with graduates like Ari Allyn-Feuer (GSK AI Products Director) and Alex Kalinin (Broad Institute). Collaborations include NIH-funded initiatives (O’Brien Kidney Core Center, VIOLIN 2.0) and industry partnerships.

Frederic Friscourtمشاهده پروفایل

دانشیار

• Chemical Biology
• Glycobiology
• Bioorthogonal Chemistry
• +۳ مورد دیگر

Frederic Friscourt is an Associate Professor in Chemical Biology at the University of Bordeaux, France, with co-affiliations at the European Institute of Chemistry and Biology (IECB) and the Institute of Molecular Sciences (ISM, CNRS UMR 5255). He leads the Friscourt Lab within the "Molecular Photonics, Chemical Biology and Imaging" (PMCI) division at ISM. His educational background includes: M.Sc. in Chemistry & Chemical Engineering Diploma (2004), University of Clermont-Ferrand PhD in Chemistry, University of Glasgow (supervised by Prof. Pavel Kočovský) Postdoctoral Fellowship (2009-2014), Complex Carbohydrate Research Center (GA, USA) under Prof. Geert-Jan Boons Friscourt's research focuses on unravelling functional roles of mammalian complex glycans through innovative chemical tool development. His lab integrates organic chemistry, enzymatic synthesis, biochemical assays, and cell imaging to advance glycomics technologies, with emphasis on bioorthogonal chemistry for selective glycan labeling in living systems. Key methodologies include strain-promoted cycloadditions and sydnone-based probes enabling real-time visualization of dynamic glycan functions. Analysis of his 15 most recent publications (2018-2023) reveals a dominant trend in developing bioorthogonal reaction platforms (particularly sydnone-cyclooctyne systems) for glycan imaging, spanning fundamental organic chemistry to biological applications in DNA labeling, sialome tagging, and neural injury studies. This work bridges chemical innovation with critical biological questions in reproductive biology, neurobiology, and host-pathogen interactions. Notable awards include: CNRS ATIP-Avenir Award for outstanding young principal investigator (2017) IdEx Bordeaux Junior Chair of Excellence in Chemical Biology Award (2014) ACS Outstanding Postdoctoral Research Chemist Award (2012) Friscourt actively mentors a growing research group, evidenced by onboarding of new members (Aïnhoa Lafourcade, Lucile Jeanneret, Audrey Baeyens, Ludovic Hirsoux in 2024-2025), and has secured competitive funding from multiple agencies. His leadership extends to organizing major scientific events including the 58th International Conference on Medicinal Chemistry (RICT 2024) and the 4th Scientific Days of the GDR ChemBio at IECB. The Friscourt Lab operates at the chemical biology frontier within ISM's PMCI division, maintaining strong collaborations and contributing to Bordeaux's prominence in glycan research through its unique integration of synthetic chemistry and live-cell imaging technologies.

• Pharmacology
• Toxicology
• Drug Abuse Research
• +۷ مورد دیگر

Brenda Gannon, Ph.D., is an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS), within the College of Medicine. Her research focuses on the abuse-related effects of novel psychoactive substances (NPS), including synthetic cannabinoids, cathinones, and opioids. She also investigates regulatory policy and drug-drug interactions. Dr. Gannon’s work employs behavioral pharmacology techniques such as intravenous self-administration, drug discrimination, and telemetry-based physiological monitoring. Education: Ph.D., Interdisciplinary Toxicology, UAMS (2015) Graduate Certificate in Regulatory Sciences, UAMS (2014) Postdoctoral Fellowship at University of Texas Health Science Center-San Antonio (2015–2018) Research Interests: Dr. Gannon’s research bridges preclinical pharmacology and regulatory science, with emphasis on understanding the neurochemical and behavioral profiles of emerging drugs. Her lab evaluates abuse liability, polypharmacology, and translational strategies for drug development. Key areas include synthetic cathinones, psychedelics, and opioid alternatives. Grant Activity: She serves as Lab Manager (Co-Investigator equivalent) on NIH-funded projects (IDs 15DDHQ24A00000020 and 15DDHQ24A00000027) investigating hallucinogens and stimulants’ abuse potential using in vivo assays. Labs/Teams: Her laboratory focuses on translational drug research, combining behavioral and neurochemical analyses to inform regulatory policy and therapeutic design.

• Neurodegeneration
• Parkinson’s Disease
• Glia
• +۷ مورد دیگر

Dr. Yuhong Fu is a Senior Research Fellow at the School of Medical Sciences , The University of Sydney , and a member of the Brain and Mind Centre . With a background in neurology and neuroscience, Fu's research focuses on glial involvement in neurodegeneration, particularly in Parkinson’s disease (PD) and related synucleinopathies. Education : MD (1996), PhD in Neuroscience (2002) on experimental autoimmune encephalomyelitis. Research Interests include: Glia in neurodegenerative diseases Alpha-synuclein pathology Lipid metabolism in PD and MSA Neuroanatomy and neuropathology Adult neurogenesis and neurorestoration Key Publications highlight astroglial protein profiles, lipid dysregulation, and glial-neuronal interactions in synucleinopathies. Recent work explores proximity ligation assays for early alpha-synuclein detection and sex-specific lipid changes in Abca7 knockout models. Scientific Awards : IDSA Foundation grant (2025) for bacterial traces in Alzheimer’s brains Michael J Fox Foundation support (2019) for glial protein studies in PD NHMRC grants (2018, 2017) for imaging platforms and mitophagy research Teaching & Supervision focuses on neuroanatomy and neurodegeneration. Current research students include Zirui Cao (Postmortem PD neural activity), Yang Liu (PD-associated genes pathobiology), and Zirui Zeng (Sleep neuron neuropathology in PD). Labs & Collaborations : Fu has worked with Neuroscience Research Australia (Paxinos’ and Halliday’s labs) and employs histology, microscopy, animal models, and molecular biology to study neurodegenerative mechanisms.

Maria Luisa Savo Sardaroمشاهده پروفایل

پژوهشگر

• Food Microbiology
• Gut Microbiota
• Probiotics and Prebiotics
• +۴ مورد دیگر

Maria Luisa Savo Sardaro is a Researcher at Northwestern University, holding a PhD in Genetics from Tuscia University (Italy). She also serves as an Assistant Professor in Food Microbiology at San Raffaele University in Rome and completed a Postdoctoral Research Fellowship at Parma University. Her research focuses on the impact of fermented and non-fermented foods on gut microbiota composition, particularly linking microbiota evolution to human health outcomes. She specializes in molecular biology and microbiological techniques for pathogen and fermentative bacteria identification, with an emphasis on probiotic and prebiotic applications in food systems. Education: PhD in Genetics, Tuscia University (Italy) Postdoctoral Fellowship, Parma University Research Interests: Maria Luisa investigates microbial dynamics in fermented foods, gut microbiota interactions, and their implications for health. Her work integrates molecular diagnostics, metagenomics, and food science to advance understanding of probiotic efficacy and fermentation processes. Current projects include studying microbiome diversity in animal populations and developing rapid screening methods for beneficial bacterial strains. Publications: Over 13 peer-reviewed articles since 2016, covering topics like microbial community analysis, fermentation optimization, and prebiotic effects. Her work bridges fundamental microbiology with applied food science, addressing both ecological and clinical questions. Grants and Advising: No specific grants or advising roles listed in the provided text. She collaborates with institutions globally on microbiology and food safety initiatives. Labs/Teams: Affiliated with Northwestern’s Anthropology department research groups, though her primary lab work occurs at Parma University and San Raffaele University. Active member of interdisciplinary teams studying food microbiology and human health intersections.

• Protein Engineering
• Enzyme Engineering
• Biocatalysis
• +۳ مورد دیگر

Prof. Ulrich Schwaneberg serves as a University Professor at RWTH Aachen University's Faculty of Mathematics, Computer Science and Natural Sciences within the Institute of Biotechnology. His research group operates from the Biology Sammelbau facility (Worringerweg 3, Aachen) and maintains strong ties with the DWI - Leibniz Institute for Interactive Materials. His primary research focuses on protein engineering and biocatalysis , with significant contributions to plastic degradation technologies (particularly PET hydrolases), material-binding peptide development , and high-throughput screening methodologies . Key research thrusts include engineering enzymes for plastic recycling, developing anchor peptides for industrial applications, and creating novel biocatalytic systems for sustainable chemistry. Recent publications reveal a strong trend toward computational-guided enzyme design (using MD simulations and machine learning) combined with practical applications in environmental remediation . His team actively develops solutions for microplastic detection, phosphate recovery, and textile functionalization using biohybrid systems. The 2025 article portfolio demonstrates particular emphasis on PET degradation technologies and enzyme immobilization strategies. Prof. Schwaneberg leads the recently launched Materials Lab Incubator (MerLIn) funded with over 7 million euros from BAFA, and coordinates the Bio4MatPro competence center connecting industry partners with academic research. His group actively recruits Chinese students through CSC fellowships and organizes the annual Aachen Protein Engineering Summer School (AcES2) . The Schwaneberg group maintains state-of-the-art facilities for directed evolution, high-throughput screening, and biocatalytic process development, with strong industry partnerships focused on sustainable material innovations. Current initiatives include the development of flame-retardant textile coatings using biohybrid anchor peptides and scalable systems for plastic upcycling.

• Oncology
• Neuro-Oncology
• Hematology
• +۵ مورد دیگر

Radu O. Minea is an Assistant Professor of Research in Neurological Surgery at the University of Southern California (USC). His research focuses on developing conjugated drug therapies for cancers such as glioblastoma, leukemia, and lymphoma. He specializes in preclinical models to evaluate the efficacy of novel compounds like NEO212, NEO214, and NEO100, which target cancer cells through mechanisms including autophagy inhibition, macrophage differentiation, and enhanced drug delivery to tumor sites. His work bridges molecular oncology, drug design, and translational medicine, with a particular emphasis on overcoming drug resistance in malignant tumors. Key research areas include: Design and testing of conjugated chemotherapeutic agents Mechanisms of drug resistance in gliomas and hematologic malignancies Targeted drug delivery strategies for brain-localized cancers Role of disintegrins and venom-derived peptides in cancer therapy Dr. Minea’s publications highlight innovations in radiosensitization, antiviral cancer therapies, and the application of multi-integrin targeting proteins. His research has implications for improving treatment outcomes in aggressive cancers like glioblastoma and acute myeloid leukemia.

Iman Azimiمشاهده پروفایل

مدرس ارشد

• Brain Cancer
• Cellular Aging
• Calcium Signaling Pathways
• +۳ مورد دیگر

Iman Azimi is a Senior Lecturer and Research Group Head in the Pharmacology Department at Monash Biomedicine Discovery Institute, Monash University. His academic journey includes a PhD from the University of New South Wales (2011), postdoctoral research at The University of Queensland (2011–2017), and a Lecturer role at the University of Tasmania (2018–2023). He leads research focused on brain cancer, cellular aging, calcium signaling, and drug discovery. His work is supported by grants from Cancer Council Tasmania, Brain Foundation, and others. Education: PhD in Pharmacology, University of New South Wales, 2011 Postdoctoral Fellowship, The University of Queensland, 2011–2017 Research Interests: Identifying therapeutic targets for brain cancers (e.g., medulloblastoma) Unraveling cellular aging mechanisms Calcium signaling in cancer and senescence High-throughput drug screening assay development Publications: Recent articles focus on LIN28 proteins in medulloblastoma, T-type calcium channel inhibitors, and calcium signaling pathways. His work bridges basic science and translational applications in cancer therapy. Awards: Includes the ASCEPT New Investigator Award (2016), Oxygen Club of California Award (2015), and multiple grants and scholarships. Leadership & Service: Chair of Institutional Biosafety Committees, Guest Editor for Cancers and Frontiers in Pharmacology , and grant reviewer for NHMRC and international agencies. Labs/Teams: Leads a research group at Monash focused on cancer and aging biology, with expertise in cell culture, fluorescence microscopy, and high-content imaging.